Methadone and Ketamine for Neuropathic Pain Treatment
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02233452|
Recruitment Status : Completed
First Posted : September 8, 2014
Last Update Posted : September 8, 2014
|Condition or disease||Intervention/treatment||Phase|
|Neuropathic Pain||Drug: Methadone Drug: Ketamine Drug: Methadone plus Ketamine||Phase 4|
Either oral methadone or ketamine have been used in neuropathic pain management, however, the benefits of the association of both drugs are uncertain. Here, we conducted a randomized, double-blind, in parallel, active controlled clinical trial to test the hypothesis that methadone combined ketamine (methadone/ketamine) is more effective than methadone or ketamine alone in reducing neuropathic pain.
Methods: Fourthly two patients with neuropathic pain refractory to conventional therapy were randomly assigned to receive during three months oral methadone (n= 13), ketamine (n=13) or methadone combined with ketamine (n=13). The primary outcome was pain score on visual analogical scale (VAS) assessed on baseline, 8, 15, 30, 60 and 90 days throughout the treatment, and the secondary outcomes were symptoms of neuropathic pain such as allodynia, burning or shooting pain as well the side effects.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||37 participants|
|Intervention Model:||Factorial Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||Management of Neuropathic Chronic Pain With Methadone Combined With Ketamine: Randomized, Double Blind, Active-controlled Clinical Trial|
|Study Start Date :||January 2012|
|Actual Primary Completion Date :||August 2012|
|Actual Study Completion Date :||August 2012|
Active Comparator: Methadone
Group treated with methadone solution.
The solution of methadone was prepared by mixing 10 ml of methadone (10 mg/ml) and 90 ml of saline 0.9% (Baxter, São Paulo, Brazil)
Other Name: Methadone hydrochloride, Cristália® (São Paulo, Brazil)
Active Comparator: Ketamine
Group treated with ketamine solution
The solution of ketamine was prepared by mixing 20 ml of S(+)-ketamine hydrochloride (50 mg/ml, Cristália®, São Paulo, Brazil) and 80 ml of saline 0.9% (Baxter, São Paulo, Brazil), obtaining a concentration of 10 mg/ml of ketamine.
Other Name: S(+)-ketamine hydrochloride, Cristália®, São Paulo, Brazil
Active Comparator: Methadone plus ketamine
Group treated with methadone plus ketamine solution
Drug: Methadone plus Ketamine
the solution of methadone, ketamine was prepared by mixing 10 ml of methadone hydrochloride (10 mg/ml, Cristália®, São Paulo, Brazil), 20 ml of S(+)-ketamine hydrochloride (50 mg/ml, Cristália®, São Paulo, Brazil) and 70 ml of saline 0.9% (Baxter, São Paulo, Brazil), obtaining a concentration of 1 mg/ml of methadone and 10 mg/ml of ketamine.
Other Name: methadone and S(+)-ketamine, Cristália®, São Paulo, Brazil
- The primary outcome was pain intensity as assessed by visual analogical scale (VAS) scores [ Time Frame: 90 days ]
- The secondary outcomes were the presence of burning and/or shooting pain, allodynia and side effects. [ Time Frame: 90 days ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02233452
|University Hospital in Santa Maria|
|Santa Maria, Rio Grande do Sul, Brazil, 97105-900|
|Principal Investigator:||Juliano Ferreira, PhD||Federal University of Santa Catarina|